Pancreatic cancer in the UK

The Lancet ◽  
2011 ◽  
Vol 378 (9796) ◽  
pp. 1050 ◽  
Author(s):  
The Lancet
Keyword(s):  
Pancreatic Cancer ◽  
The Uk

scholarly journals Traditional and Novel Adiposity Indicators and Pancreatic Cancer Risk: Findings from the UK Women’s Cohort Study

Cancers ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 1036
Author(s):  
Sangeetha Shyam ◽  
Darren Greenwood ◽  
Chun-Wai Mai ◽  
Seok Shin Tan ◽  
Barakatun Nisak Mohd Yusof ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cohort Study ◽  
Cancer Risk ◽  
Reverse Causality ◽  
Hip Circumference ◽  
Primary Analysis ◽  
Pancreatic Cancer Risk ◽  
Obesity Indices ◽  
The Uk

(1) Background: We studied the association of both conventional (BMI, waist and hip circumference and waist–hip ratio) and novel (UK clothing sizes) obesity indices with pancreatic cancer risk in the UK women’s cohort study (UKWCS). (2) Methods: The UKWCS recruited 35,792 women from England, Wales and Scotland from 1995 to 1998. Cancer diagnosis and death information were obtained from the National Health Service (NHS) Central Register. Cox’s proportional hazards regression was used to evaluate the association between baseline obesity indicators and pancreatic cancer risk. (3) Results: This analysis included 35,364 participants with a median follow-up of 19.3 years. During the 654,566 person-years follow up, there were 136 incident pancreatic cancer cases. After adjustments for age, smoking, education and physical activity, each centimetre increase in hip circumference (HR: 1.03, 95% CI: 1.01–1.05, p = 0.009) and each size increase in skirt size (HR: 1.12, 95% CI: 1.02–1.23, p = 0.041) at baseline increased pancreatic cancer risk. Baseline BMI became a significant predictor of pancreatic cancer risk (HR: 1.04, 95% CI: 1.00–1.08, p = 0.050) when latent pancreatic cancer cases were removed. Only baseline hip circumference was associated with pancreatic cancer risk (HR: 1.03, 95% CI: 1.00–1.05, p = 0.017) when participants with diabetes at baseline were excluded to control for reverse causality. (4) Conclusion: Hip circumference and skirt size were significant predictors of pancreatic cancer risk in the primary analysis. Thus, hip circumference is useful to assess body shape relationships. Additionally, standard skirt sizes offer an economical and objective alternative to conventional obesity indices for evaluating pancreatic cancer risk in women.

scholarly journals Coffee and pancreatic cancer risk among never‐smokers in the UK prospective Million Women Study

2018 ◽  
Vol 145 (6) ◽  
pp. 1484-1492 ◽  
Author(s):  
Charlie D Zhou ◽  
Ai Seon Kuan ◽  
Gillian K Reeves ◽  
Jane Green ◽  
Sarah Floud ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Risk ◽  
Pancreatic Cancer Risk ◽  
Never Smokers ◽  
The Uk

Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK

2003 ◽  
Vol 4 (3) ◽  
pp. 216-221 ◽  
Author(s):  
Mike Aristides ◽  
Michael Lees ◽  
Nick Botwood ◽  
Jan McKendrick ◽  
Deborah A Stephenson ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Economic Evaluation ◽  
The Uk

Pancreatic cancer

2018 ◽  
pp. 387-398
Author(s):  
Abdullah Jibawi ◽  
Mohamed Baguneid ◽  
Arnab Bhowmick
Keyword(s):  
Pancreatic Cancer ◽  
Weight Loss ◽  
Abdominal Pain ◽  
Abdominal Ultrasound ◽  
Serum Marker ◽  
Whipple Procedure ◽  
Fine Needle ◽  
Multidisciplinary Assessment ◽  
The Uk ◽  
Ct And Mri

Pancreatic cancer is the tenth most common cancer in the UK and is most often incurable at diagnosis. Presentation is generally with weight loss, jaundice, and or abdominal pain. Abdominal ultrasound, CT and MRI may be diagnostic. Tissue diagnosis is not usually necessary, but endoscopic ultrasound can obtain fine needle samples. The serum marker CA19-9 may be raised, but is not a screening test. Potentially curable lesions need careful multidisciplinary assessment for resectability, and a thorough assessment of patient fitness. The Whipple procedure is discussed as well as laparoscopic pancreatectomy. Adjuvant chemotherapy and palliative gemcitabine therapy are also covered.

scholarly journals Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position

2020 ◽  
Vol 123 (5) ◽  
pp. 709-713 ◽  
Author(s):  
Christopher M. Jones ◽  
Ganesh Radhakrishna ◽  
Katharine Aitken ◽  
John Bridgewater ◽  
Pippa Corrie ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
The Uk

scholarly journals Reply to Comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic”

2020 ◽  
Author(s):  
Christopher M. Jones ◽  
Ganesh Radhakrishna ◽  
Katharine Aitken ◽  
John Bridgewater ◽  
Pippa Corrie ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
The Uk

scholarly journals PCN8: ECONOMIC EVALUATION OF GEMZAR IN THE TREATMENT OF PANCREATIC CANCER IN THE UK

2001 ◽  
Vol 4 (2) ◽  
pp. 86-87
Author(s):  
D Stephenson ◽  
N Botwood ◽  
J McKendrick ◽  
M Aristides ◽  
M Lees ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Economic Evaluation ◽  
The Uk

scholarly journals Intraoperative radiotherapy for pancreatic cancer: implementation and initial experience

2021 ◽  
Author(s):  
R Bhome ◽  
D Karavias ◽  
T Armstrong ◽  
Z Hamady ◽  
A Arshad ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Treatment Modality ◽  
Intraoperative Radiotherapy ◽  
Initial Experience ◽  
Multicentre Trials ◽  
The Uk ◽  
To Receive

This article reports on the first series of patients to receive intraoperative radiotherapy for pancreatic cancer in the UK. The data suggest that this treatment modality is feasible and safe, laying a platform for collaborative multicentre trials to better assess efficacy.

scholarly journals Barriers to shared decisions in the most serious of cancers: a qualitative study of patients with pancreatic cancer treated in the UK

2014 ◽  
Vol 18 (6) ◽  
pp. 3302-3312 ◽  
Author(s):  
Sue Ziebland ◽  
Alison Chapple ◽  
Julie Evans
Keyword(s):  
Pancreatic Cancer ◽  
Qualitative Study ◽  
The Uk
Sign in / Sign up

Export Citation Format

Share Document